top of page
The Professional Network for Healthcare Experts
Sanofi and Regeneron expand immunology alliance in deal worth up to $8bn
Sanofi and Regeneron have expanded their long-running immunology alliance with four next-generation antibody programmes in a deal worth up to $8 billion.
nuaxia
Oct 22 min read
Sanofi and Cheplapharm agree transfer of 20 mature medicines and three manufacturing sites
Sanofi and Cheplapharm have agreed a major mature-medicines transaction covering 20 products and three manufacturing sites in France, Hungary and Singapore.
nuaxia
Sep 162 min read
Sanofi and Lilly Back AdvanCell’s $315M Radiopharmaceutical Expansion as ADVC001 Moves Towards Late-Stage Development
Funding round will support development of lead targeted alpha therapy ADVC001 in metastatic prostate cancer and expand Lead-212 manufacturing capabilities.
nuaxia
Jul 173 min read
Sanofi’s Sarclisa Escena Receives FDA Approval as First Oncology Drug Delivered Through On-Body Injector
The FDA has approved Sarclisa Escena, a subcutaneous on-body injector formulation of Sanofi’s multiple myeloma therapy isatuximab, becoming the first cancer treatment authorised in the US for delivery through an on-body injector system. Sanofi has secured US Food and Drug Administration (FDA) approval for Sarclisa Escena, a new subcutaneous (SC) formulation of its multiple myeloma therapy Sarclisa (isatuximab-irfc) delivered through an on-body injector (OBI). The approval rep
nuaxia
Jul 133 min read
bottom of page